Who makes the brand name for infliximab?
•
4 min read
The first tumor necrosis factor-alpha (TNF-α) inhibitor, Remicade® (infliximab), received its initial marketing approval from the US Food and Drug Administration (FDA) in 1998. The original manufacturer of the brand name for infliximab is Janssen Biotech, Inc., a subsidiary of Johnson & Johnson. With the expiration of patent protections, the market now also includes several biosimilar versions of infliximab.
